Bristol Myers Squibb sues Biden administration over Medicare drug negotiations in third such lawsuit

Bristol Myers Squibb said its blood thinner Eliquis will be subject to the negotiations this year. Eliquis is used to prevent blood clots and strokes.

Previous post : The next step in California’s reparations push is ‘the most thrilling’: turning proposals into reality
Next post : U.S. financial regulators say they’re tracking exposures to commercial real estate as vacancy rates rise, especially for office space